Board Meeting30 Oct 2026, 06:02 pm

Kabra Drugs Ltd Board Meeting on Nov 6 to Approve Q2 Unaudited Results

AI Summary

Kabra Drugs Ltd has announced that its Board of Directors will convene on November 6, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026. The meeting will be held at the company's registered office in Chennai. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Highlights

Board meeting scheduled for November 6, 2026.
To approve unaudited financial results for Q2 FY27.
Meeting to be held at the registered office.
Compliance with SEBI LODR Regulations.

View BSE Filing

KABRADG

Pharmaceuticals

KABRA DRUGS LTD.

Price Impact